8:35am ET
Investing
Top Analyst Downgrades, Stocks to Sell: Apple, Twitter, First Solar and More
These are the top analyst downgrades and cautious research notes from Wall Street for Monday, January 6.
Companies
Alexion Pharmaceuticals, Inc.
$182.50
â–² $0.00 (+0.00%) today
Markets closed · 8:54pm ET
ALXN Coverage
Page 19
7:25am ET
Health and Healthcare
Solid Biotech Stocks With the Best Revenue Growth for 2014
ThinkstockAny time investors look for companies growing sales the most, one area that almost always stands out is the up and coming biotech stocks. After all, sales can grow from close to…
8:25am ET
Health and Healthcare
UBS Picks Large Cap Biotechnology Stocks to Outperform the Rest of 2013
ThinkstockEven though the equity strategy team at UBS has downgraded U.S. equities to Neutral from Outperform, they remain very positive on large cap biotechnology names. Acknowledging in their recent report that the…
8:15am ET
Health and Healthcare
Cowen’s Eight Biotech Stocks to Buy That Could Beat Earnings: Alexion, Ariad and More
ThinkstockBiotechnology stocks have had an extremely solid first half of the year. The analysts at Cowen Group point out that expectations are very high and many of the stocks have already made…
8:10am ET
Investing
Ten Top Large Cap Stocks to Buy With the Most Upside Potential
When we screen stocks at the Wall Street firms we cover, we always are anxious to provide our readers with the stocks that the top firms feel have the most upside from…
8:15am ET
Health and Healthcare
Merrill Lynch Top Biotechnology Stocks to Buy for Big Gains
ThinkstockThe higher the market climbs, the harder it becomes for investors to find solid stock ideas to add or scale in to their portfolios. With the market currently teetering on what seems…
8:10am ET
Health and Healthcare
Deutsche Bank Firm on Biotech Stocks to Buy
ThinkstockBiotech has strongly outperformed the S&P 500 since January of 2011. The NASDAQ Biotechnology Index (NBI) is up 90%, and the AMEX Biotechnology index (BTK) is up 50%, versus the 28% gain…
8:15am ET
Investing
UBS Top Picks for Second Quarter for 25 Percent Gains (ALXN, ACI, C, CIE, DAL, HAL, BLOX, KRA, MNST, NCT, ROST, TIBX, WCRX, WFM)
When we started off 2013, most of the Wall St. firms we follow put out their top stock picks for the year. We covered those various lists so our readers could get…
12:50pm ET
Health and Healthcare
ETF Folly: Biotech ETFs, Nothing but Confusion
Thinkstock24/7 Wall St. has always wondered about the confusing universe of biotech exchange-traded funds (ETFs). Biotech stocks can rise or fall regardless of the market direction, and the sector performed very well…
8:20am ET
Investing
Top Analyst Upgrades and Downgrades (ACMP, ALXN, ADI, BIDU, BCS, ESRX, GMCR, LOW, MM, NTSP, RDN, SEE, SPLS, HOT, WIN)
Jon OggThese are some of this Wednesday’s top analyst upgrades, downgrades and initiations seen from Wall St. research calls. Access Midstream Partners L.P. (NYSE: ACMP) reiterated Outperform but on Focus List at…
9:50am ET
Health and Healthcare
Analyst Calls Cancer Treatments Major Biotech Focus in 2013 (AMGN, GSK, ALXN, ARIA, CELG, INCY, ONXX)
ThinkstockThe dread and fear that can come with a cancer diagnosis have their roots in its killer nature. It is the number two cause of death in Americans, second only to heart…
7:27am ET
Health and Healthcare
The Big Biotech Winners and Losers for 2013 (AMGN, BIIB, CELG, GILD, ALXN, ARIA, CBST, INCY, JAZZ, MDVN, ONXX, THRX, VPHM, VVUS)
ThinkstockBig biotech had a stellar 2012. In 2013, though, the large biotech companies may be dwarfed in performance by the smaller players in the $1 billion to $5 billion range. If you…
2:57pm ET
Health and Healthcare
How Overvalued Are the Biggest Biotechs? (AMGN, BIIB, GILD, ALXN)
The largest biotech stocks have been great performers in 2012. The question is whether that can be sustained in 2013. If Wall St. analysts are correct, biotech and biohealth investors are going…
8:04am ET
Health and Healthcare
Short Interest in Biotech Remains Mixed (ALXN, AMGN, ARNA, BIIB, CELG, DNDN, GILD, ILMN, ONXX, PCYC, REGN, VRTX, VVUS, IBB)
ThinkstockWe have tracked the key short interest changes in the following biotech and emerging pharma companies: Alexion Pharmaceuticals Inc. (NASDAQ: ALXN), Amgen Inc. (NASDAQ: AMGN), Arena Pharmaceuticals Inc. (NASDAQ: ARNA), Biogen Idec…
7:41am ET
Health and Healthcare
Short Interest in Biotech Is Mixed (ALXN, AMGN, ARNA, BIIB, CELG, DNDN, GILD, ILMN, ONXX, PCYC, REGN, VRTX, VVUS, IBB)
We have tracked the key short interest changes in the following biotech and emerging pharma companies: Alexion Pharmaceuticals Inc. (NASDAQ: ALXN), Amgen Inc. (NASDAQ: AMGN), Arena Pharmaceuticals Inc. (NASDAQ: ARNA), Biogen Idec…